OOIR: Observatory of International Research

Papers

(The H4-Index of JAMA Psychiatry is 66. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Combination Antidepressant Therapy vs Monotherapy—Further Considerations	1078
Potential Limitations for Assessing Adverse Posttraumatic Neuropsychiatric Sequelae With Wrist-Wearable Device and Self-report Survey	598
Assumptions and Limitations of the Synthetic Control Method	525
Error in Results	353
Further Considerations on Early Intervention for Borderline Personality Disorder—Reply	306
JAMA Psychiatry	255
JAMA Psychiatry	254
Integrating Financing Variables Into Behavioral Health Policy Implementation Research	219
An Opportunity to Advance Cannabis Science—DEA Rescheduling	205
JAMA Psychiatry	205
The Reliability of Traumatic and Adverse Experiences	185
Diagnosing and Treating ADHD in Adults	168
Overmystifying the Psychedelic Experience	160
Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode	158
TikTok Challenges—Unintentional Injuries vs Suicide Attempts	153
Error in Abstract	150
Left Ventrolateral Prefrontal Cortical Activity During Reward Expectancy and Mania Risk	141
Neighborhood Disadvantage and Autism Spectrum Disorder in a Population With Health Insurance	138
Issues in Clinical Trial Design—Lessons From the FDA’s Rejection of MDMA	137
Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders	135
Managerial and Organizational Challenges in the Age of AI	135
Polygenic Contributions to Lithium Augmentation Outcomes in Unipolar Depression	135
Effect of Culturally Tailored, Internet-Delivered Cognitive Behavioral Therapy for Insomnia in Black Women	133
Brief Cognitive Behavioral Therapy for Suicidal Military Personnel and Veterans	131
Accelerated Theta-Burst Stimulation for Treatment-Resistant Depression	130

Prenatal Adversities and Risk of Persistent Youth Psychopathology and Altered Cortical Thinning	124
Associations Between Objective and Subjective Experiences of Childhood Maltreatment and the Course of Emotional Disorders in Adulthood	122
Consistency of Delusion Themes Across First and Subsequent Episodes of Psychosis	117
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder	116
Patients Use AI—Clinicians Should Ask How	113
JAMA Network Call for Papers on Health and the 2024 US Election	112
JAMA Psychiatry	104
Error in the Caption of Figures 2, 3, 4, and 5 and in Supplement 1	100
Error in Byline	97
Living Alone and Drug Overdose Deaths in the US	97
Association of Frailty With Risk of Suicide Attempt in a National Cohort of US Veterans Aged 65 Years or Older	96
Perinatal Mental Health Outcomes Following Natural Disasters	96
Addiction Medicine Physicians and Medicinal Cannabinoids	94
Military Sexual Trauma in the United States	93
The Role of Energy Homeostasis in Depression Pathophysiology and Its Heterogeneity	91
Hyperalgesia in Patients With a History of Opioid Use Disorder	91
Effect of a Tobacco Cessation Intervention Incorporating Weight Management for Adults With Serious Mental Illness	90
Evaluation of Post–COVID-19 Cognitive Dysfunction: Recommendations for Researchers	87
Adolescent Mental Health Care and Stigma	85
Women With Schizophrenia—Ignored and Aging	85
Mental Health Impairment and Outpatient Mental Health Care of US Children and Adolescents	84
Searching the Brain for the Cause of Psychosis	84
Efficacy of Augmentation of Cognitive Behavioral Therapy With Transcranial Direct Current Stimulation for Depression	83
Risk for Mood, Anxiety, and Psychotic Disorders in Individuals at High and Low Genetic Liability for Bipolar Disorder and Major Depression	83
Serotonin 4 Receptor Brain Binding in Major Depressive Disorder and Association With Memory Dysfunction	83
US Veterans Affairs and Department of Defense 2023 Clinical Guideline for PTSD—Devolving Not Evolving	82
COVID-19 and Mental Health in Young People—Causality or Co-occurrence?	79
Associating Violence With Schizophrenia—Risks and Biases—Reply	77
Etiologic Studies of Premenstrual Disorders Require Prospective Confirmation of Affective Cyclicity	75
Combination Antidepressant Therapy vs Monotherapy—Further Considerations	73
JAMA Psychiatry	73
Limitations for Assessing Optimism and Physical Functioning in Women—Reply	71
Measures of General Intelligence and Risk for Alcohol Use Disorder	70
War Exposure and DNA Methylation in Syrian Refugee Children and Adolescents	69
Does Vaccination Really Mitigate Psychiatric Implications of COVID-19?—Reply	69
JAMA Psychiatry	69
Physician Suicide and Associated Features—What Defines a Physician?	68
Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs	68
Implementation Strategies Used and Reported in Brief Suicide Prevention Intervention Studies	68
Sweetened Beverages and Incident All-Cause Dementia Among Older Adults	68
Genetic Liabilities Differentiating Bipolar Disorder, Schizophrenia, and Major Depressive Disorder, and Phenotypic Heterogeneity in Bipolar Disorder	66